International Journal of Medical Sciences

Impact factor
2.399

18 December 2017

ISSN 1449-1907 News feeds of published articles

My Manuscript | My Account

Journal of Biomedicinenew

Theranostics

Journal of Cancer

Oncomedicine

International Journal of Biological Sciences

Journal of Genomics

Journal of Bone and Joint Infection (JBJI)

Nanotheranostics

PubMed Central Indexed in Journal Impact Factor

Int J Med Sci 2013; 10(3):265-275. doi:10.7150/ijms.5344

Research Paper

Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Discovery of Novel Akt2 Inhibitors

Jia Fei1, Lu Zhou1✉, Tao Liu1, Xiang-Yang Tang2

1. College of Chemical Engineering, Sichuan University, Sichuan, Chengdu, 610065, China;
2. College of Computer Science, Southeast University for Nationalities, Sichuan, Chengdu, 610041, China.

Abstract

Akt2 is considered as a potential target for cancer therapy. In order to find novel Akt2 inhibitors which have different scaffolds, structure-based pharmacophore model and 3D-QSAR pharmacophore model were built and validated by different methods. Then, they were used for chemical databases virtual screening. The selected compounds were further analyzed and refined using drug-like filters and ADMET analysis. Finally, seven hits with different scaffolds were picked out for docking studies. These seven hits were predicted to have high inhibitory activity and good ADMET properties, they may act as novel leads for Akt2 inhibitors designing.

Keywords: Akt2, inhibitor, pharmacophore, docking, virtual screening.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Fei J, Zhou L, Liu T, Tang XY. Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Discovery of Novel Akt2 Inhibitors. Int J Med Sci 2013; 10(3):265-275. doi:10.7150/ijms.5344. Available from http://www.medsci.org/v10p0265.htm